Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AptarGroupATR -0.27%85 Days Payable is 0.00 as of Jun. 2026. GuruFocus rates ATR with a GF Score™ of 85/100 and a GF Value™ of $159.87 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 796 Medical Devices & Instruments companies, AptarGroup ranks worse than 66.58% on this metric.
AptarGroup's average Accounts Payable for the
three
months ended in Jun. 2026 was $0 Mil. AptarGroup's Cost of Goods Sold for the
three
months ended in Jun. 2026 was $661 Mil.
Hence, AptarGroup's Days Payable for the
three
months ended in Jun. 2026 was 0.00.
The historical rank and industry rank for AptarGroup's Days Payable or its related term are showing as below:
ATR'
s Days Payable Range Over the Past 10 Years
Min: 28.13 Med: 44.93 Max: 53.24
Current: 49.44
During the past 13 years, AptarGroup's highest Days Payable was 53.24. The lowest was 28.13. And the median was 44.93.
ATR's Days Payable is ranked worse than 66.58% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.04
vs ATR: 49.44
AptarGroup's Days Payable
stayed the same
from Jun. 2025 (0.00) to Jun. 2026 (0.00).
stayed the same
The historical data trend for AptarGroup's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AptarGroup's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AptarGroup Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's Days Payable distribution charts can be found below:
* The bar in red indicates where AptarGroup's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
AptarGroup's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AptarGroup (ATR) has a Days Payable of 0.00 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AptarGroup and its competitors. Over the past decade, AptarGroup's Days Payable has ranged from 28.13 to 53.24. According to the industry distribution chart, AptarGroup ranks #530 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 66.6%.
Is AptarGroup's Days Payable too high?
AptarGroup's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 28.13 to a high of 53.24. Based on the distribution chart, AptarGroup ranks #530 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AptarGroup has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AptarGroup's Days Payable compare to AVTR and RGEN?
According to the Medical Devices & Instruments industry distribution chart, AptarGroup ranks #530 out of 796 companies for Days Payable. This places AptarGroup in the lower half of its industry. The industry median Days Payable is 68.04. Historically, AptarGroup's own Days Payable has ranged from 28.13 to 53.24 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.04, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AptarGroup and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AptarGroup's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AptarGroup stock overvalued right now?
Based on GuruFocus' analysis, AptarGroup (ATR) is currently considered Modestly Undervalued. The stock's GF Value™ is $159.87, compared to a current price of $135.42 — trading 15.3% below its estimated fair value. The current Days Payable is 0.00. AptarGroup's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For AptarGroup (ATR), the current Days Payable is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AptarGroup (ATR) Overvalued in 2026?
Based on GuruFocus' analysis, AptarGroup stock appears to be undervalued.
The current stock price of $135.42 is trading 15.3% below its estimated GF Value™ of $159.87.
GuruFocus considers AptarGroup to be Modestly Undervalued.
Key valuation signals for ATR:
Days Payable: 0.00
GF Value™: $159.87 vs. price of $135.42 (15.3% below fair value)
No single metric tells the full story. See the ATR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
85GF Score
Get the complete analysis for ATR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATR has been successfully added to your 
